Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Malignant melanoma: modern black plague and genetic black box.

Literature DB >> 9832500

Malignant melanoma: modern black plague and genetic black box.

L Chin¹, G Merlino, R A DePinho.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1998 PMID： 9832500 DOI： 10.1101/gad.12.22.3467

Source DB: PubMed Journal: Genes Dev ISSN： 0890-9369 Impact factor: 11.361

Keyword Cloud
Cited

× No keyword cloud information.

39 in total

Review 1. Melanoma: from mutations to medicine.

Authors: Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal: Genes Dev Date: 2012-06-01 Impact factor: 11.361

Review 2. Growth factors and oncogenes as targets in melanoma: lost in translation?

Authors: Lawrence Kwong; Lynda Chin; Stephan N Wagner
Journal: Adv Dermatol Date: 2007

3. Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.

Authors: Victoria Marsh Durban; Marian M Deuker; Marcus W Bosenberg; Wayne Phillips; Martin McMahon
Journal: J Clin Invest Date: 2013-11-08 Impact factor: 14.808

4. Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation.

Authors: Damia Tormo; Aleix Ferrer; Evelyn Gaffal; Jörg Wenzel; Etiena Basner-Tschakarjan; Julia Steitz; Lukas C Heukamp; Ines Gütgemann; Reinhard Buettner; Marcos Malumbres; Mariano Barbacid; Glenn Merlino; Thomas Tüting
Journal: Am J Pathol Date: 2006-08 Impact factor: 4.307

5. Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R.

Authors: Kerrington R Molhoek; Amber L Shada; Mark Smolkin; Sudhir Chowbina; Jason Papin; David L Brautigan; Craig L Slingluff
Journal: Melanoma Res Date: 2011-08 Impact factor: 3.599

6. The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma.

Authors: Eric K Lee; Zhaorui Lian; Kurt D'Andrea; Richard Letrero; WeiQi Sheng; Shujing Liu; J Nathaniel Diehl; Dariusz Pytel; Olena Barbash; Lynn Schuchter; Ravi Amaravaradi; Xiaowei Xu; Meenhard Herlyn; Katherine L Nathanson; J Alan Diehl
Journal: Mol Cell Biol Date: 2013-09-09 Impact factor: 4.272

Malignant melanoma: modern black plague and genetic black box.

Review 1. Melanoma: from mutations to medicine.

Review 2. Growth factors and oncogenes as targets in melanoma: lost in translation?

3. Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma.

4. Rapid growth of invasive metastatic melanoma in carcinogen-treated hepatocyte growth factor/scatter factor-transgenic mice carrying an oncogenic CDK4 mutation.

5. Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R.

6. The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma.

7. Invasive melanoma in Cdk4-targeted mice.

8. Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model.

9. Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.

10. Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas.